enow.com Web Search

  1. Ads

    related to: targeted therapy for hodgkin's lymphoma

Search results

  1. Results from the WOW.Com Content Network
  2. Targeted therapy - Wikipedia

    en.wikipedia.org/wiki/Targeted_therapy

    Targeted therapy or molecularly targeted therapy is one of the major modalities of medical treatment ... It is used to treat melanoma, Hodgkin's lymphoma, ...

  3. MOPP (chemotherapy) - Wikipedia

    en.wikipedia.org/wiki/MOPP_(chemotherapy)

    The treatment is usually administered in four week cycles, often for six cycles. MSD and VCR are administered intravenously, while procarbazine and prednisone are pills taken orally. A newer Hodgkin lymphoma treatment is ABVD. C-MOPP involves switching the nitrogen mustard from mechlorethamine to cyclophosphamide.

  4. Chemotherapy regimen - Wikipedia

    en.wikipedia.org/wiki/Chemotherapy_regimen

    non-Hodgkin lymphoma: RdC lenalidomide (Revlimid), dexamethasone, cyclophosphamide: AL amyloidosis R-Benda rituximab + bendamustine: follicular lymphoma and MALT lymphoma [7] R-DHAP or DHAP-R: rituximab + DHAP; that is, rituximab, dexamethasone (a steroid hormone), cytarabine (ara-C), platinum agent: relapsed non-Hodgkin's lymphoma and Hodgkin ...

  5. Brentuximab vedotin - Wikipedia

    en.wikipedia.org/wiki/Brentuximab_vedotin

    Brentuximab vedotin [6] consists of the chimeric monoclonal antibody brentuximab (cAC10, which targets the cell-membrane protein CD30) linked with maleimide attachment groups, cathepsin-cleavable linkers (valine-citrulline), and para-aminobenzylcarbamate spacers to three to five units of the antimitotic agent monomethyl auristatin E (MMAE, reflected by the 'vedotin' in the drug's name). [7]

  6. ABVD - Wikipedia

    en.wikipedia.org/wiki/ABVD

    Treatment-related leukemias are uncommon with ABVD, especially as compared with MOPP. [4] However, one study found a risk of second cancers as high as 28% at 25 years after treatment for Hodgkin lymphoma, although most of the patients in this study were treated with MOPP chemotherapy rather than ABVD. [9]

  7. Stanford V - Wikipedia

    en.wikipedia.org/wiki/Stanford_V

    Stanford V (usually spoken as Stanford Five), is a chemotherapy regimen (with accompanying Radiation therapy) intended as a first-line treatment for Hodgkin lymphoma.The regimen was developed in 1988, with the objective of maintaining a high remission rate while reducing the incidence of acute and long term toxicity, pulmonary damage, and sterility observed in alternative treatment regimens ...

  1. Ads

    related to: targeted therapy for hodgkin's lymphoma